(Q44435109)

English

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

scientific article published on May 8, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911 (English)

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

phase II clinical trial

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

David G. Maloney

4

object named as

David G Maloney

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

object named as

Oliver W. Press

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738671

31 December 2023

author name string

Michael LeBlanc

6

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Joseph M. Unger

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738671

31 December 2023

Rita M. Braziel

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738671

31 December 2023

Thomas P. Miller

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738671

31 December 2023

Ellen R. Gaynor

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738671

31 December 2023

Saul E. Rivkin

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738671

31 December 2023

Richard I. Fisher

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738671

31 December 2023

language of work or name

0 references

publication date

8 May 2003

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

full work available at URL

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

102

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1606-1612

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

1

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University

3

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Follicular lymphomas: do histologic subtypes predict outcome?

4

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Long-term follow-up of patients with low-grade malignant lymphomas treated with doxorubicin-based chemotherapy or chemoimmunotherapy.

5

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial

6

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

7

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy

9

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.

10

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas.

13

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Treatment with ibritumomab tiuxetan radioimmunotherapy in patients with rituximab-refractory follicular non-Hodgkin's lymphoma

16

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Phase I/II trial of IDEC-Y2B8 radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma

17

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Randomized controlled trial of yttrium-90-labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade, follicular, or transformed B-cell non-Hodgkin's lymphoma.

20

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Second malignancies as a consequence of nucleoside analog therapy for chronic lymphoid leukemias

21

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Nonparametric Estimation from Incomplete Observations

22

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

23

1 reference

10.1182/BLOOD-2003-01-0287

https://api.crossref.org/works/10.1182/BLOOD-2003-01-0287

31 December 2023

Identifiers

10.1182/BLOOD-2003-01-0287

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44435109&oldid=2044280929"